Your welcome, I am trading around a large core position. I fully expect this to be above $2 by year's end. They have a phase 1 or 2 data being released in early 2017. Short term the chart is really shaping up and still trading below cash, only a matter of time for a big move IMO....
$NEOT, 1.44, watch for 1.52 break sends it to 1.88, chart & catalyst:
Plans to begin a new P2 trial during 3Q16 evaluating modified formulation w/ topline data expected during 1Q17. Plans to begin P2 proof of concept trial during 3Q16 to reduce fat deposits under chin (submental fat) w/ topline data expected by YE16, being developed as novel injected formulation of drug approved in several inhaled products (e.g. ADVAIR)
Market Data 
Markets 
AI
